Grant of Options

RNS Number : 0036R
Plant Health Care PLC
25 June 2020
 

25 June 2020

Plant Health Care plc

("Plant Health Care" or the "Company")

Grant of options in Lieu of Cash bonus

Plant Health Care®, a leading provider of novel patent-protected biological products to global agriculture markets, is pleased to announce an options grant to two Executive Directors on 24 June 2020. In line with previous years, these Directors alongside other senior management of the Company have agreed to receive 50% of their potential 2020 bonus in the form of stock options (the "Bonus Scheme"). As part of the Bonus Scheme, options over a total of 853,659 ordinary shares of 1p each were granted to Jeffrey Tweedy and Jeffrey Hovey, Executive Directors of the Company.  This is required to now be announced due to Jeffery Hovey and Jeffrey Tweedy being appointed to the Board on 1 November 2019.

The Company aims to reduce cash burn as much as possible to shorten the runway to cash break even, and the Bonus Scheme will help reduce the cash burn of the Company significantly over the next twelve months.

The options will be issued under the 2017 Employee Share Option Plan and were made in accordance with the terms of a share option agreement approved by the Company's Remuneration Committee, under which the options have an exercise price of £0.10, have a 10-year life and are subject to performance conditions. These awards will only vest if the Company achieves a certain financial result and if, in addition, specific annual objectives are met as a result the final awards under the Bonus Scheme to the Directors may be less.







Plant Health Care plc

Chris Richards - CEO

Jeffrey Hovey - Chief Financial Officer

 

+1 919 926 1600

 

Arden Partners plc

John Llewellyn-Lloyd / Dan Gee-Summons

+44 207 614 5900

 



 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

 

 

a)

Name

Mr Jeffrey Hovey

 

 

2.

Reason for the Notification

 

 

a)

Position/status

Chief Financial Officer

 

 

b)

Initial notification/ Amendment

Initial notification

 

 

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

 

a)

Name

Plant Health Care plc

 

 

b)

LEI

213800KBQPJZ2FM8QH27

 

 

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

 

 

Identification code

GB00B01JC540

 

 

b)

Nature of the transaction

Grant of options

 

 

c)

Price(s) and volume(s)

Price

Volume

 

 

10.0p

325,203

 

 

d)

Aggregated information:

· Aggregated volume

· Price

 

325,203

As above

 

 

e)

Date of the transaction

24 June 2020

 

 

f)

Place of the transaction

Outside a trading venue

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mr Jeffrey Tweedy

2.

Reason for the Notification

a)

Position/status

Chief Operating Officer

b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Plant Health Care plc

b)

LEI

213800KBQPJZ2FM8QH27

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 1p each

Identification code

GB00B01JC540

b)

Nature of the transaction

Grant of options

c)

Price(s) and volume(s)

Price

Volume

10.0p

528,455

d)

Aggregated information:

· Aggregated volume

· Price

 

528,455

As above

e)

Date of the transaction

24 June 2020

f)

Place of the transaction

Outside a trading venue

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHSESFULESSEEM
UK 100

Latest directors dealings